FIELD: biotechnology, in particular microbiology, individual selection of drugs for tuberculosis treatment.
SUBSTANCE: claimed kit based on Levenshtine-Jensen medium comprises 8 flacks. Four flacks additionally contain antituberculosis drugs, namely isoniaside, rifampicin, strepromicin, and ethambutol, respectively. Two flacks additionally contain sodium salicylate and thiophenecarboxy hydrazide, respectively, and two flacks are used as control ones. Additionally kit contains one flack with Griss reagent.
EFFECT: kit for accelerated examination of drug sensitivity and simultaneous identification of tuberculosis mycobacteria.
4 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIAGNOSIS OF SENSITIVITY OF MYCOBACTERIUM TUBERCULOSIS TO ANTITUBERCULOSIS PREPARATIONS | 2005 |
|
RU2315113C2 |
| METHOD FOR ESTIMATING ANTIMYCOBACTERIAL ACTION OF ANTI-TUBERCULOSIS DRUGS USING BIOLOGICAL MATERIAL OF PATIENTS WITH PULMONARY TUBERCULOSIS | 2017 |
|
RU2677972C1 |
| METHOD OF DETERMINING DRUG SUSCEPTIBILITY OF TUBERCULOSIS MYCOBACTERIA | 2003 |
|
RU2255977C1 |
| CULTURE MEDIUM FOR DETERMINING DRUG SUSCEPTIBILITY OF M tuberculosis TO MAIN ANTI-TUBERCULOSIS DRUGS | 2010 |
|
RU2470071C2 |
| STRAIN MYCOBACTERIUM TUBERCULOSIS 326/18/47 B-9673 FOR EVALUATION OF THE EFFECTIVENESS OF ANTI-TB DRUGS AND DISINFECTANTS | 2022 |
|
RU2785409C1 |
| NUTRIENT MEDIUM FOR ACCELERATED ASSAY OF MEDICINAL RESISTANCE OF MYCOBACTERIUM TUBERCULOSIS | 2001 |
|
RU2226398C2 |
| MEANS, POSSESSING ANTI-TUBERCULOSIS ACTION | 2014 |
|
RU2549477C1 |
| AGENT EXHIBITING BACTERIOSTATIC ACTIVITY ON MULTIRESISTANT MYCOBACTERIUM TUBERCULOSIS STRAINS IN EXPERIMENT | 2015 |
|
RU2602450C1 |
| ANTI-TUBERCULOSIS AGENT | 2017 |
|
RU2657423C1 |
| METHOD FOR INACTIVATION OF DRUG-SENSITIVE AND DRUG-RESISTANT STRAINS OF MYCOBACTERIUM TUBERCULOSIS IN EXPERIMENTAL CONDITIONS IN VITRO | 2018 |
|
RU2702646C1 |
